Prothena Corp Public Ltd Co financial data

Symbol
PRTA on Nasdaq
Industry
Pharmaceutical Preparations
Location
77 Sir John Rogerson's Quay, Block C, Grand Canal Docklands, Dublin 2, Ireland
State of incorporation
Ireland
Fiscal year end
December 31
Former names
Prothena Corp plc (to 5/22/2020), Neotope Corp Ltd (to 10/1/2012)
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.24K % +4.58%
Debt-to-equity 19.9 % -21.3%
Return On Equity -9 % +64.6%
Return On Assets -7.51 % +63%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 53.8M shares +0.46%
Common Stock, Shares, Outstanding 53.8M shares +0.52%
Entity Public Float 2.9B USD +203%
Common Stock, Value, Issued 538K USD +0.56%
Weighted Average Number of Shares Outstanding, Basic 53.8M shares +1.22%
Weighted Average Number of Shares Outstanding, Diluted 55M shares +3.62%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 217M USD +277%
Research and Development Expense 241M USD +36%
General and Administrative Expense 67.2M USD +25.9%
Operating Income (Loss) -91.4M USD +47.3%
Nonoperating Income (Expense) 30M USD +53.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -61.4M USD +60.1%
Income Tax Expense (Benefit) -10.5M USD +18.6%
Net Income (Loss) Attributable to Parent -50.9M USD +63.9%
Earnings Per Share, Basic -0.94 USD/shares +65.6%
Earnings Per Share, Diluted -0.96 USD/shares +64.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 564M USD -14.4%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Assets, Current 586M USD -13.5%
Deferred Income Tax Assets, Net 39.5M USD +52.2%
Property, Plant and Equipment, Net 3.49M USD +60.6%
Operating Lease, Right-of-Use Asset 12.1M USD +265%
Other Assets, Noncurrent 3.69M USD -67.2%
Assets 646M USD -10.4%
Accounts Payable, Current 9.29M USD -33%
Employee-related Liabilities, Current 9.43M USD +13.9%
Liabilities, Current 46.7M USD -34.7%
Operating Lease, Liability, Noncurrent 9.54M USD
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 63.6M USD -54.2%
Retained Earnings (Accumulated Deficit) -985M USD -5.45%
Stockholders' Equity Attributable to Parent 582M USD +0.04%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 582M USD +0.04%
Liabilities and Equity 646M USD -10.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -73.1M USD -53.9%
Net Cash Provided by (Used in) Financing Activities 836K USD -96.4%
Net Cash Provided by (Used in) Investing Activities -103K USD -115%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 53.8M shares +0.52%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 565M USD -14.6%
Deferred Tax Assets, Valuation Allowance 182M USD +12.8%
Deferred Tax Assets, Gross 219M USD +21%
Operating Lease, Liability 12.1M USD +251%
Depreciation 900K USD +28.6%
Lessee, Operating Lease, Liability, to be Paid 13.7M USD -24.6%
Property, Plant and Equipment, Gross 11.3M USD -17.5%
Operating Lease, Liability, Current 2.58M USD -25.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.16M USD +3.47%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.18M USD +12.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.63M USD +3292%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.27M USD +3.52%
Deferred Tax Assets, Operating Loss Carryforwards 156M USD +14.3%
Unrecognized Tax Benefits 13.4M USD +15.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.52M USD -22.8%
Operating Lease, Payments 0 USD -100%
Additional Paid in Capital 1.57B USD +3.38%
Depreciation, Depletion and Amortization 215K USD +6.97%
Deferred Tax Assets, Net of Valuation Allowance 37.1M USD +87.8%